{"id":24089,"date":"2026-05-26T00:47:43","date_gmt":"2026-05-26T00:47:43","guid":{"rendered":"https:\/\/www.europesays.com\/france\/24089\/"},"modified":"2026-05-26T00:47:43","modified_gmt":"2026-05-26T00:47:43","slug":"drugmaker-sanofi-to-expand-india-gcc-increase-workforce-to-over-4500-employees","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/france\/24089\/","title":{"rendered":"Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees"},"content":{"rendered":"<p>Feb 16 (Reuters) &#8211; French drugmaker Sanofi <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/SASY.PA\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(SASY.PA), opens new tab<\/a> said on Monday it will expand its global capability centre (GCC) in the southern Indian city of Hyderabad, and increase its workforce to more than 4,500 employees.<\/p>\n<p>The centre currently employs over 2,600 people.<\/p>\n<p data-testid=\"promo-box\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__promo-box__hVl8h\"> Sign up  <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/world\/india\/drugmaker-sanofi-expand-india-gcc-increase-workforce-over-4500-employees-2026-02-16\/undefined?location=article-paragraph&amp;redirectUrl=%2Fworld%2Findia%2Fdrugmaker-sanofi-expand-india-gcc-increase-workforce-over-4500-employees-2026-02-16%2F\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p>The biopharmaceutical company said that the expansion would be supported by a &#8220;multi-hundred-million&#8221; investment, but did not disclose the exact size of the amount. It also did not specify a timeframe for the hiring.<\/p>\n<p>In 2024, Sanofi said it would invest 400 million euros ($474.60 million) in its India GCC by the end of the decade.<\/p>\n<p>Multinational companies are increasingly setting up so-called global capability centres in India, which have evolved from low-cost back offices to high-value innovation hubs that support operations, finance, research and development.<\/p>\n<p>India hosts more than 1,700 GCCs, employing over 1.9 million professionals, according to real estate consultancy Anarock.<\/p>\n<p>The consultancy projects the GCC market to reach $105 billion\u2013$110 billion by 2030, expanding at a 10% CAGR, and estimates the number of centres could rise to more than 2,400 by then, driven by a larger talent pool and broader sectoral diversification.<\/p>\n<p>The latest hiring would include specialists in research and development, artificial intelligence and data innovation, data analytics, medical affairs, commercial capabilities and corporate functions, Sanofi Healthcare India, part of the global group, said in a statement.<\/p>\n<p>The announcement comes as Hyderabad prepares to host its annual BioAsia conference on February 17 and 18, where executives from global drugmakers, including Eli Lilly <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/LLY.N\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(LLY.N), opens new tab<\/a>, Sanofi, Novo Nordisk <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/NOVOb.CO\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(NOVOb.CO), opens new tab<\/a> and Merck <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/MRCG.DE\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(MRCG.DE), opens new tab<\/a>, will discuss expanding research and the growth outlook for India&#8217;s pharma market.<\/p>\n<p>($1 = 0.8428 euros)<\/p>\n<p>(This story has been refiled to correct a typographical error in paragraph 9)<\/p>\n<p data-testid=\"SignOff\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__full_width__kCIGb body-module__extra_small_body__Bfz20 sign-off-module__text__LQAMP\">Reporting by Rishika Sadam and Kashish Tandon; Editing by Eileen Soreng<\/p>\n<p data-testid=\"Body\" dir=\"ltr\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__element__5eCce article-body-module__trust-badge__5mS3f\">Our Standards: <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.thomsonreuters.com\/en\/about-us\/trust-principles.html\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__medium__2Rl30 text-module__small__sph8i link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n<p><a href=\"https:\/\/www.reutersagency.com\/en\/licensereuterscontent\/?utm_medium=rcom-article-media&amp;utm_campaign=rcom-rcp-lead\" target=\"_blank\" dir=\"ltr\" class=\"button-module__link__A3sD0 button-module__secondary__70gBu button-module__round__QDFgq button-module__w_auto__Sem-F\" data-testid=\"LicenceContentButton\" rel=\"nofollow noopener\">Purchase Licensing Rights<\/a><a data-testid=\"AuthorBioImageLink\" class=\"author-bio-module__author-image__jcaG3\" href=\"https:\/\/www.reuters.com\/authors\/rishika-sadam\/\" referrerpolicy=\"no-referrer-when-downgrade\" tabindex=\"-1\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/france\/wp-content\/uploads\/2026\/05\/https:\/\/author-service-images-prod-us-east-1.publishing.aws.arc.pub\/reuters\/02b67da6-dd98-4ba9-8926-.jpeg\" alt=\"Rishika Sadam\"\/><\/a><\/p>\n<p data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__base__o--Cl body-module__extra_small_body__Bfz20 author-bio-module__description__9ynkB\">Rishika leads Reuters\u2019 coverage of India\u2019s pharmaceutical and healthcare sector. Her reporting focuses on key themes such as the emergence of weight-loss drugs, the country\u2019s drug regulatory framework and manufacturing quality standards, and developments shaping India\u2019s pharmaceutical exports to major markets including the United States and Europe. She also covers the country\u2019s rapidly growing hospital industry. With nearly a decade of experience in journalism, Rishika has previously reported extensively on Indian politics, national elections, and on social affairs and criminal justice.<\/p>\n","protected":false},"excerpt":{"rendered":"Feb 16 (Reuters) &#8211; French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it will expand its&hellip;\n","protected":false},"author":2,"featured_media":24090,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12983],"tags":[1517,9336,17705,17706,1885,17707,1917,1910,1918,1919,1907,1922,1915,17722,1923,1926,1908,17718,17719,17721,1928,1920,1930,1909,1914,1927,1925,17716,17717,1924,17720,1902,9337,1899,1900,1903,1889,17708,17709,689,5893,1905,17710,17711,17712,17713,1895,17703,13012,17715,17724,17704,17723,1897,17714],"class_list":["post-24089","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sanofi","tag-asia","tag-asxpac","tag-bact","tag-biz","tag-cmpny","tag-cprod","tag-destabn","tag-destabx","tag-destafa","tag-destbnx","tag-destcsa","tag-destdnp","tag-deste","tag-destef-business-world-at-work","tag-destfun","tag-destgns","tag-destlby","tag-destnoinbsm","tag-destnointim","tag-destolgrb","tag-destpco","tag-destpsc","tag-destrbn","tag-destreulb","tag-destrnp","tag-destrws","tag-destrwsa","tag-destsni","tag-destsns","tag-destucdptest","tag-efbusiness-world-at-work","tag-emea","tag-emrg","tag-europ","tag-ezc","tag-fr","tag-gen","tag-hea","tag-heca","tag-in","tag-job","tag-mtpix","tag-phag08","tag-phar","tag-phar1","tag-phmr","tag-publ","tag-rhpiemployee-health","tag-sanofi","tag-sasia","tag-topcmb","tag-topicpharma-healthcare-healthcare-innovation","tag-topnws","tag-weu","tag-xpand"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/24089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/comments?post=24089"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/24089\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media\/24090"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media?parent=24089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/categories?post=24089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/tags?post=24089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}